SCHEMBL8283197

SCHEMBL8283197

CC(C)(C)OC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ccc(C(C)(C)C)cc2)CCCCC1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.70
CTSD P07339 16/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6041060 1.00 BACE1 (0.70) BACE1CTSD
SCHEMBL5736679 0.91 BACE1 (0.84) BACE1CTSD
SCHEMBL5668634 0.91 BACE1 (0.83) BACE1CTSD
SCHEMBL8283198 0.91 BACE1 (0.83) BACE1CTSD
SCHEMBL5734242 0.91 BACE1 (0.84) BACE1CTSD
SCHEMBL5666356 0.89 BACE1 (0.84) BACE1CTSD
SCHEMBL5669845 0.88 BACE1 (0.85) BACE1CTSD
SCHEMBL8282482 0.88 BACE1 (0.85) BACE1CTSD
SCHEMBL6522393 0.88 BACE1 (0.85) BACE1CTSD
SCHEMBL8282579 0.86 BACE1 (0.65) BACE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005087215-A1 SUBSTITUTED UREA AND CARBAMATE, PHENACYL-2-HYDROXY-3-DIAMINOALKANE, AND BENZAMIDE-2-HYDROXY-3-DIAMINOALKANE ASPARTYL-PROTEASE INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-09-22 WO disclosed
WO-2005070407-A1 METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-08-04 WO disclosed